换一批
第一作者：
Mirjam,Renovanz
第一单位：
Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.;Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.;Department of Neurosurgery, Eberhard Karls University Tübingen, Germany.
作者：
Mirjam,Renovanz [1]
;
Sylvia C,Kurz [2]
;
Johannes,Rieger [2]
;
Bianca,Walter [3]
;
Hannes,Becker [1]
;
Hanni,Hille [3]
;
Paula,Bombach [4]
;
David,Rieger [2]
;
Lucia,Grosse [2]
;
Lara,Häusser [5]
;
Marco,Skardelly [2]
;
Daniel J,Merk [3]
;
Frank,Paulsen [6]
;
Elgin,Hoffmann [6]
;
Cihan,Gani [7]
;
Manuela,Neumann [8]
;
Rudi,Beschorner [8]
;
Olaf,Rieß [9]
;
Cristiana,Roggia [10]
;
Christopher,Schroeder [10]
;
Stephan,Ossowski [10]
;
Sorin,Armeanu-Ebinger [10]
;
Axel,Gschwind [10]
;
Saskia,Biskup [11]
;
Martin,Schulze [12]
;
Falko,Fend [13]
;
Stephan,Singer [13]
;
Lars,Zender [14]
;
Claudia,Lengerke [15]
;
Sara Yvonne,Brucker [16]
;
Tobias,Engler [16]
;
Andrea,Forschner [17]
;
Arnulf,Stenzl [18]
;
Oliver,Kohlbacher [19]
;
Sven,Nahnsen [20]
;
Gisela,Gabernet [21]
;
Sven,Fillinger [21]
;
Benjamin,Bender [22]
;
Ulrike,Ernemann [22]
;
Öznur,Öner [23]
;
Janina,Beha [23]
;
Holly Sundberg,Malek [23]
;
Yvonne,Möller [23]
;
Kristina,Ruhm [23]
;
Marcos,Tatagiba [24]
;
Jens,Schittenhelm [8]
;
Michael,Bitzer [25]
;
Nisar,Malek [25]
;
Daniel,Zips [7]
;
Ghazaleh,Tabatabai [26]
作者单位：
Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.;Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.;Department of Neurosurgery, Eberhard Karls University Tübingen, Germany.
[1]
Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.;Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.
[2]
Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.
[3]
Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.;Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.;Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.
[4]
Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
[5]
Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.;Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.;Department of Radiation Oncology, Eberhard Karls University Tübingen, Germany.
[6]
Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.;Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.;Department of Radiation Oncology, Eberhard Karls University Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
[7]
Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.;Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.;Institute of Pathology and Neuropathology, Department of Neuropathology, Eberhard Karls University Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
[8]
Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.;Institute of Medical Genetics and Applied Genomics, Eberhard Karls University Tübingen, Germany.;Cluster of Excellence (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University of Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
[9]
Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.;Institute of Medical Genetics and Applied Genomics, Eberhard Karls University Tübingen, Germany.
[10]
Center for Genomics and Transcriptomics (CeGaT) & Center for Human Genetics Tübingen, Germany.;Cluster of Excellence (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University of Tübingen, Germany.
[11]
Center for Genomics and Transcriptomics (CeGaT) & Center for Human Genetics Tübingen, Germany.
[12]
Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.;Department of Pathology and Neuropathology, Institute of Pathology and Molecular Pathology, Eberhard Karls University Tübingen, Germany.;Cluster of Excellence (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University of Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
[13]
Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.;Department of Medical Oncology and Pneumology (Internal Medicine VIII), Eberhard Karls University Tübingen, Germany.;Cluster of Excellence (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University of Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
[14]
Department of Internal Medicine II, Eberhard Karls University Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
[15]
Department of Gynecology and Obstetrics, Eberhard Karls University Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
[16]
Department of Dermatology and Center for Dermato-Oncology, Eberhard Karls University Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
[17]
Department of Urology, Eberhard Karls University Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
[18]
Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.;Institute for Translational Bioinformatics, Eberhard Karls University Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
[19]
Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.;Quantitative Biology Center (QBiC), Eberhard Karls University Tübingen, Germany.;Department of Medical Oncology and Pneumology (Internal Medicine VIII), Eberhard Karls University Tübingen, Germany.;Cluster of Excellence (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University of Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
[20]
Quantitative Biology Center (QBiC), Eberhard Karls University Tübingen, Germany.
[21]
Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.;Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.;Department of Diagnostic and Interventional Neuroradiology, Department of Radiology, Eberhard Karls University Tübingen, Germany.
[22]
Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.
[23]
Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.;Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.;Department of Neurosurgery, Eberhard Karls University Tübingen, Germany.
[24]
Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.;Department of Internal Medicine I, Eberhard Karls University Tübingen, Germany.;Cluster of Excellence (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University of Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
[25]
Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.;Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.;Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.;Cluster of Excellence (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University of Tübingen, Germany.;German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
[26]
DOI
10.1093/noajnl/vdad012
PMID
36915613
发布时间
2023-03-15
- 浏览0
Neuro-oncology advances
Neuro-oncology advances
vdad012页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
